|
Naltrexone Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: LDN
Pipeline
Phase 1: 1Phase 2: 1Phase 2/3: 1
Top Sponsors
- Sarah Weiss1
- Dartmouth-Hitchcock Medical Center1
- AgelessRx1
Indications
- Geroscience1
- Longevity1
- GLP - 11
- Painful Diabetic Neuropathy1
- Weight Loss1
Chicago, Illinois1 trial
Lebanon, New Hampshire1 trial
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
Dartmouth-Hitchcock Medical Center
Phase 2
New Brunswick, New Jersey1 trial
Naltrexone and Propranolol Combined With Immunotherapy
Rutgers Cancer Institute of New Jersey
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.